Safety and Efficacy of R0.6C Vaccine
NCT04862416
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Malaria,Falciparum
Interventions
BIOLOGICAL:
R0.6C transmission blocking vaccine
Sponsor
Radboud University Medical Center
Collaborators
[object Object]
[object Object]